China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,185 | 2,461 | 2,740 | 3,755 | 6,249 |
| Marketable Securities | 46 | 21 | 40 | N/A | N/A |
| Receivables | 682 | 1,087 | 2,456 | 4,224 | 5,465 |
| Inventories | 3,589 | 5,055 | 6,407 | 7,311 | 9,663 |
| Other current assets | 0 | 0 | 461 | 2,004 | 2,533 |
| TOTAL | $5,579 | $8,747 | $12,290 | $17,520 | $24,249 |
| Non-Current Assets | |||||
| PPE Net | 16,314 | 19,294 | 23,541 | 24,968 | 29,393 |
| Investments And Advances | 0 | 17,070 | 23,723 | 35,498 | 42,031 |
| Intangibles | 206 | 266 | 399 | 535 | 841 |
| Other Non-Current Assets | 137 | 0 | 0 | 0 | 0 |
| TOTAL | $16,656 | $36,630 | $47,663 | $61,000 | $72,265 |
| Total Assets | $22,235 | $45,377 | $59,953 | $78,520 | $96,514 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,150 | 2,181 | 2,305 | 1,440 | 1,541 |
| Accounts payable and accrued liabilities | 6,999 | 5,760 | 5,354 | 6,918 | 5,889 |
| Accrued Expenses | 190 | 311 | 276 | 140 | 143 |
| Other current liabilities | 505 | 526 | 581 | 811 | 596 |
| TOTAL | $10,045 | $10,052 | $9,227 | $10,398 | $12,791 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,150 | 4,363 | 6,916 | 8,641 | 10,785 |
| Other Non-Current Liabilities | 49 | 0 | 0 | 0 | 0 |
| TOTAL | $2,952 | $5,127 | $7,655 | $9,213 | $11,082 |
| Total Liabilities | $12,998 | $15,179 | $16,882 | $19,611 | $23,873 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87 | 87 | 87 | 87 | 87 |
| Common Shares | 44 | 44 | 44 | 44 | 44 |
| Retained earnings | -25,972 | -5,270 | 5,480 | 24,757 | 33,940 |
| Other shareholders' equity | 11,576 | 11,835 | 13,958 | 10,518 | 15,067 |
| TOTAL | $9,238 | $30,199 | $43,071 | $58,909 | $72,641 |
| Total Liabilities And Equity | $22,235 | $45,377 | $59,953 | $78,520 | $96,514 |